Manganese‐Based Immunomodulatory Nanocomposite with Catalase‐Like Activity and Microwave‐Enhanced ROS Elimination Ability for Efficient Rheumatoid Arthritis Therapy
Xiaotong Chen, Lianying Zhang, Haifeng Zeng, Wei Meng, Guijiang Liu, Wen‐Hua Zhang, Pei Zhao, Qun Zhang, Ming Chen, Jin-Xiang Chen
Abstract
Abstract Rheumatoid arthritis (RA) is a chronic autoimmune disease commonly associated with the accumulation of hyperactive immune cells (HICs), particularly macrophages of pro‐inflammatory (M1) phenotype, accompanied by the elevated level of reactive oxygen species (ROS), decreased pH and O 2 content in joint synovium. In this work, an immunomodulatory nanosystem (IMN) is developed for RA therapy by modulating and restoring the function of HICs in inflamed tissues. Manganese tetraoxide nanoparticles (Mn 3 O 4 ) nanoparticles anchored on UiO‐66‐NH 2 are designed, and then the hybrid is coated with Mn‐EGCG film, further wrapped with HA to obtain the final nanocomposite of UiO‐66‐NH 2 @Mn 3 O 4 /Mn‐EGCG@HA (termed as UMnEH). When UMnEH diffuses to the inflammatory site of RA synovium, the stimulation of microwave (MW) irradiation and low pH trigger the slow dissociation of Mn‐EGCG film. Then the endogenously overexpressed hydrogen peroxide (H 2 O 2 ) disintegrates the exposed Mn 3 O 4 NPs to promote ROS scavenging and O 2 generation. Assisted by MW irradiation, the elevated O 2 content in the RA microenvironment down‐regulates the expression of hypoxia‐inducible factor‐1α (HIF‐1α). Coupled with the clearance of ROS, it promotes the re‐polarization of M1 phenotype macrophages into anti‐inflammatory (M2) phenotype macrophages. Therefore, the multifunctional UMnEH nanoplatform, as the IMN, exhibits a promising potential to modulate and restore the function of HICs and has an exciting prospect in the treatment of RA.